Attributes | Values |
---|
rdf:type
| |
Description
| - Dvojitě zaslepená randomizovaná multicentrická studie zaměřená na srovnání efektu lipidového komplexu Amfotericinu B a jeho kombinace s Mycograbem, protilátkou proti HS proteinu 90 u pacientů s invazivní kandidiazou. Mycograb byl dobře tolerován. Bylo prokázáno statisticky významné snížení mortality i hodnocených mikrobiologických parametrů (cs)
- A double-blind, randomized study was conducted to determine whether lipid-associated amphotericin B plus Mycograb (NeuTec)is superior to amphotericin B plus placebo in patients with culture-confirmed invasive candidiasis. Mycograbrab was well tolerated. Mycograb plus lipid-associated amphotericin B produced significant clinical and culture-confirmed improvement in outcome for patients with invasive candidiasis
- A double-blind, randomized study was conducted to determine whether lipid-associated amphotericin B plus Mycograb (NeuTec)is superior to amphotericin B plus placebo in patients with culture-confirmed invasive candidiasis. Mycograbrab was well tolerated. Mycograb plus lipid-associated amphotericin B produced significant clinical and culture-confirmed improvement in outcome for patients with invasive candidiasis (en)
|
Title
| - A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of heat shock protein 90 in patients with invasive candidiasis
- A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of heat shock protein 90 in patients with invasive candidiasis (en)
- Randomizovaná, zaslepená, multicentrická studie se samostatně podaným lipidovým komplexem amfotericinu nebo v kombinaci s protilátkou inhibující HS 90 u pacientů s invazivní candidiazou (cs)
|
skos:prefLabel
| - A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of heat shock protein 90 in patients with invasive candidiasis
- A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of heat shock protein 90 in patients with invasive candidiasis (en)
- Randomizovaná, zaslepená, multicentrická studie se samostatně podaným lipidovým komplexem amfotericinu nebo v kombinaci s protilátkou inhibující HS 90 u pacientů s invazivní candidiazou (cs)
|
skos:notation
| - RIV/00216208:11120/06:00000947!RIV09-MSM-11120___
|
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| |
http://linked.open...iv/cisloPeriodika
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/00216208:11120/06:00000947
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - invasive candidiasis; heat shock protein inhibitor; HS 90; heat shock protein antibody (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...odStatuVydavatele
| - US - Spojené státy americké
|
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...i/riv/nazevZdroje
| - Clinical Infectious Diseases
|
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...v/svazekPeriodika
| |
http://linked.open...iv/tvurceVysledku
| - Svoboda, P.
- Pachl, Jan
- Drgona, L.
- Aoun, M.
- Burnie, J.
- Garbino, J.
- Jacobs, F.
- Malbrain, M.
- Masterson, G.
- Matthews, R.
- Spronk, P.
- Takala, J.
- Vandewoude, K.
- van der Hoven, B.
|
http://linked.open...ain/vavai/riv/wos
| |
issn
| |
number of pages
| |
http://localhost/t...ganizacniJednotka
| |